The decision reaffirming the FDA's oversight authority over cell and gene therapy products was praised by the International ...

Researchers explored whether the uptake of pre-test education and cancer risk genetic testing was similar for patients who used a chatbot or met with a genetic counselor.

Four US cancer centers are partnering with leading technology firms to analyze cancer patient data while maintaining privacy and regulatory compliance.

The radiopharmaceutical, already approved for SSRT-expressing GEP-NETs, may be a new option in meningioma if future research ...

With help from the oversubscribed financing round, the Australian firm is eyeing early 2025 for a Phase I clinical trial of its TAG-72-targeting cell therapy.

The firm will use the funding to begin a first-in-human trial of its autologous macrophage cell therapy in liver disease.

The firm sees potential for AI algorithms to support drug development by screening patients for biomarkers and predicting their responses to cancer therapies.